TherapeuticsMD, Inc.TXMDNASDAQ
Loading
Year-over-year revenue growth rate
Percentile
P31
Within normal range
vs 5Y Ago
-0.2x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -17.65% |
| Q2 2025 | 142.24% |
| Q1 2025 | -41.08% |
| Q4 2024 | 21.94% |
| Q3 2024 | 133.76% |
| Q2 2024 | -25.24% |
| Q1 2024 | -37.65% |
| Q4 2023 | 1047.17% |
| Q3 2023 | -112.13% |
| Q2 2023 | 5.05% |
| Q1 2023 | -63.89% |
| Q4 2022 | -94.49% |
| Q3 2022 | -26.76% |
| Q2 2022 | 47.73% |
| Q1 2022 | 3.51% |
| Q4 2021 | -26.48% |
| Q3 2021 | 10.46% |
| Q2 2021 | 15.78% |
| Q1 2021 | -12.01% |
| Q4 2020 | 16.73% |
| Q3 2020 | 80.75% |
| Q2 2020 | -12.65% |
| Q1 2020 | -22.96% |
| Q4 2019 | -32.96% |
| Q3 2019 | 290.20% |
| Q2 2019 | 54.03% |
| Q1 2019 | -22.46% |
| Q4 2018 | 46.52% |
| Q3 2018 | -7.69% |
| Q2 2018 | -0.28% |
| Q1 2018 | -8.51% |
| Q4 2017 | -6.64% |
| Q3 2017 | 3.93% |
| Q2 2017 | 6.65% |
| Q1 2017 | -11.19% |
| Q4 2016 | -18.94% |
| Q3 2016 | 25.72% |
| Q2 2016 | -10.69% |
| Q1 2016 | -12.43% |
| Q4 2015 | 8.47% |